Please see the links below for details about some helpful GI organizations.
See the helpful information below for new patients, questions and answers, and helpful resources.
Before an appointment can be scheduled, you will need a referral from your physician.
West Coast Gastroenterology
5th floor-2775 Laurel Street
Vancouver, BC, V5Z 1M9
© 2025 West Coast Gastroenterology
Dr. Sundeep Singh is a Gastroenterologist with a special interest in the Inflammatory Bowel Diseases (IBD)
Dr. Singh completed his undergraduate Bachelor of Science at the University of Winnipeg. He then attended the University of Manitoba to complete his Bachelor of Science in Medicine and his Medical Degree. Subsequently, he completed his Internal Medicine residency at the University of Alberta, followed by his Gastroenterology fellowship at the University of Calgary. He then pursued an Advanced Inflammatory Bowel Disease Fellowship at the University of Calgary before his arrival in Kelowna to join the Kelowna Gastroenterology Associates. He practised here for 8 years before accepting a position at Vancouver General Hospital to help run the IBD clinic.
Dr. Singh has research interests in IBD surgical outcomes, IBD epidemiology and IBD risk factors and has published research within various recognized Gastroenterology journals including the American Journal of Gastroenterology, Clinical Gastroenterology & Hepatology and Gastroenterology. He now continues his research with clinical trials including evaluation of novel biologic therapeutic targets and long term safety profiles for biologics.
Rioux LC, Charbonneau J, McHugh K, Siffledeen J, Singh S, Afif W, Targownik L. Treatment patterns for advanced therapies in Canadians with moderate-to-severe Inflammatory Bowel Disease. Manuscript submitted to Journal of the Canadian Association of Gastroenterology, under review
Painchaud M, Singh S, Penner RM. Similar Outcomes in Patients Switched to Infliximab Biosimilars Compared to Those Remaining on Remicade in a British Columbia Inflammatory Bowel Disease Practice, Journal of the Canadian Association of Gastroenterology, Volume 5, Issue Supplement_1, March 2022, Pages 20–21, https://doi.org/10.1093/jcag/gwab049.146
Shim R, Haskey N, Ye J, Singh S, Gibson D. Mediterranean Diet compliance in patients with ulcerative colitis. UBCO Interdisciplinary Conference 2021 (Abstract)
Bernstein CN, Singh S, Graff LA, Walker J, Miller N, Cheang M. A Prospective Population-based Study of Triggers of Symptomatic Flares in IBD. Am J Gastroenterol. 2010 Sept;105(9):1994-2002. Epub 2010 Apr 6
Recipient of a Crohn’s Colitis Canada Grant in dietary research in IBD
American College of Gastroenterology (ACG) Fellow Award
American College of Gastroenterology (ACG) Annual North American Conference of Gastroenterology Fellows
American Gastroenterological Association (AGA) Research Foundation – Horizon Resident Abstract Prize
The Polly & George Sheps Prize
Mindel & Tom Olenick Scholarship
Dr. John Adamson and Dr. Sanford T. Fleming Studentship
Dr. Ian Gan MD, FRCPC is a gastroenterologist at Vancouver General Hospital and a Clinical Associate Professor of Medicine at the University of British Columbia. He specializes in advanced therapeutic endoscopy with a focus towards pancreaticobiliary disease. He acts as the chair and director of the West Coast Pancreas Clinic.
He was the former head of endoscopic ultrasound and the GI Fellowship Program at Tufts University, before moving to Virginia Mason Medical Center in Seattle, Washington. He was the program director for gastroenterology training at University of Washington. After almost ten years at VMMC, he moved back home to Vancouver. Dr. Gan has authored 75 publications in gastroenterology, mostly focusing on clinical research in pancreaticobiliary diseases.
Dr. Peter Kwan is a gastroenterologist at Vancouver General Hospital and a Clinical Associate Professor in the Faculty of Medicine at UBC.
He has completed his medical training at University of Western Ontario and university of British Columbia. He pursued further post-fellowship training at National Institute of Health, Bethesda and in Department of Medical Genetics at UBC.
He has extensive experience in assessment and management of general gastrointestinal disorders, with special interest in hepatitis B and metabolic-associated liver diseases, with research study in these two patient populations. He is fluent in English and Cantonese.
Dr. Roberto Trasolini is a gastroenterologist and therapeutic endoscopist at Vancouver General Hospital. He specializes in advanced endoscopy and general gastroenterology.
Dr. Trasolini uses a range of endoscopic tools and techniques to provide minimally invasive treatments for GI diseases including endoscopic submucosal dissection (ESD), endoscopic suturing, fluoroscopy/ERCP, and endoscopic ultrasound (EUS).
He has a special interest in endoscopic suturing, endoscopic ultrasound guided anastomosis creation, as well as third space endoscopy. He is working to bring novel treatments for obesity and metabolic syndrome to Canada and British Columbia inspired by his fellowship training.
He has published numerous abstracts, papers and videos in advanced endoscopy. He is a clinical supervisor for the UBC Advanced Endoscopy Fellowship.
Dr. Daljeet Chahal MD MASc FRCPC is a gastroenterologist and hepatologist at Vancouver General Hospital, and a Clinical Assistant Professor at the University of British Columbia.
Dr. Chahal practices in all areas of general Gastroenterology and Hepatology. He is a member of the Liver Transplant Program of BC and is involved in transplant assessment, care during critical illness, and care of patients after transplantation including immunosuppression management.
Dr. Chahal has published various conference abstracts, journal articles, and book chapters on various topics in Gastroenterology and Liver Diseases.
Dr. Chahal’s clinical and translational research interests include studies aiming to better characterize complications of acute-on-chronic liver failure, and studies to reduce ischemic complications after liver transplantation.
Dr. Chahal is also involved in clinical trials of novel therapeutic compounds for patients affected by various types of liver disease. He is the co-editor of “AI in Clinical Medicine.” He is fluent in English and Punjabi
Dr. Michael Byrne MD, FRCPC is a Clinical Professor of Medicine in the Division of Gastroenterology, and Director of the Interventional Endoscopy Fellowship program at Vancouver General Hospital/University of British Columbia.
He is also the CEO and founder of Satisfai Health, a company using Artificial Intelligence and allied technologies across the spectrum of GI diseases. He is frequently described as one of the pioneers in bringing AI to Gastroenterology and Endoscopy.
He has published over 150 papers in peer-reviewed journals, over 200 abstracts, and is the lead editor for a recent textbook from the publisher Wiley, entitled “AI in Clinical Medicine”.
He frequently presents at international conferences, particularly in relation to Artificial Intelligence and Gastroenterology.
Dr. Isabella Tai is a Clinician-Scientist with a special interest in Gastrointestinal cancers. She is interested in understanding the mechanisms of chemotherapy resistance, metastasis and tumour progression in gastrointestinal cancers. Her group uses genomic and proteomic approaches to identify genetic markers that could be suitable for colorectal cancer screening, and to identify unique signatures that correspond to drug resistance in colorectal cancers.
Dr. Nazira Chatur MD, FRCPC is a gastroenterologist at Vancouver General Hospital with more than 25 years of clinical experience. She is the current Section Head for Gastroenterology in BC and the President of the BC Society of Gastroenterology. She is a gastroenterologist and endoscopist with special interest and extensive experience in inflammatory bowel disease (IBD). As well, she has published on colonic neoplasms in childhood survivors of malignancy and continues to service this patient population.
Additionally, she is the GI lead on the BC Cancer Association (BCCA) Task Force for immune checkpoint inhibitor related adverse events. Previously, she worked for over 10 years in IT, such as Motorola in the area of radio network telecommunications including secure data transmission using encryption and decryption. This resulted in a joint patent.
Dr. Eric Yoshida OBC, MD, MHSc, FRCP(C), FACP, FACG, FCAHS, FAASLD is a Professor of Medicine at University of British Columbia. He has had more than 30 years of experience in management of common liver disorders as well as extensive clinical and research expertise in viral hepatitis and liver transplant. He has had over 385 peer-reviewed publications in medical and scientific journals, over 160 non-peer-reviewed publications, and 30 miscellaneous articles.
He has been an author or co-author on over 350 abstracts presented around the world. He has been extremely active in leadership roles in the academic and medical communities. He is the current Co-Chair of the Canadian Association for the Study of the Liver (CASL) new Diversity and Equality Committee, Current Chair of Medical Advisory Committee of the National Canadian Liver Foundation since 2010. He is the founder and the current editor-in-chief of the Canadian Liver Journal. He has held several leadership roles, including the President of Vancouver General Hospital Medical, Dental, and Allied Staff Association, the Vancouver Physician Staff Association, the Head of Gastroenterology at UBC, the head of Gastroenterology at Vancouver General Hospital, the Medical Director of BC’s Liver Transplant Program, and President of CASL.
He is passionate about providing care to marginalized and underserved population.
Dr. Gray MD, CCFP, ABIM, FRCPC, CAGF is a Clinical Professor of Medicine at UBC. Born and raised in Vancouver, BC, he has been an active member of the Gastroenterology Division at Vancouver General Hospital since 1989.
He is an appointed Fellow of the Canadian Association of Gastroenterology. He has been the President of the BC Society of Gastroenterology and served as the Medical Advisor to the GI Society and Badgut.Org. He has been a Board member of the Canadian Society of Intestinal Research, and has been involved as co-Chair in the Guidelines and Protocol Advisory Committee to the BC Medical Commission.
He is a current examiner for the Royal College of Physicians and Surgeons of Canada in Gastroenterology. He is a DOPS assessor (Direct Observation of Procedural Skills) as part of the provincial program for quality assurance during colonoscopy.
Dr. Sarvee Moosavi MD, FRCPC, MEd. (Candidate) is a clinical assistant professor in gastroenterology at Vancouver General Hospital. She practices in all areas of general Gastroenterology and Hepatology. In addition, she sees complex referrals from all around the province for disorders of gut-brain interaction (formerly known as functional GI disorders), as well as neurogastroenterology and GI motility disorders.
She is the founder of the only gastroenterology motility lab in the province of British Columbia with access to both esophageal and anorectal manometry, where she personally performs high-quality tests assessing gastrointestinal function, including esophageal and anorectal manometry, pH monitoring, and esophageal planimetry (EndoFLIP). She has first authored several articles in highly reputable journals, as well as the “Atlas of High-Resolution Manometry and pH Monitoring”.
She has presented at international and national conferences on various topics on disorders of gut-brain interaction and esophageal motility disorders. She is fluent in both English and Farsi.
Dr. Vladimir Marquez MD, FRCPC, MSc. is a gastroenterologist and hepatologist with subspecialty training in liver transplantation with over 10 years of clinical experience.
He is currently the Medical Lead of the Liver Transplant Program at Vancouver General Hospital. He is particularly interested in the management of portal hypertension. In his general hepatology clinics, he manages various conditions including PBC, PSC, viral hepatitis, alcohol-related liver disease, Wilson’s disease, and steatohepatitis.
He has research interests in liver transplantation,
portal hypertension, and Wilson disease, and has served as an investigator on clinical trials in these areas. He is fluent in English, Spanish, and French.
Dr. Baljinder Salh MBChB FRCP(UK) FRCP(C) is a gastroenterologist at Vancouver General Hospital and an Associate Professor in the Faculty of Medicine at UBC. He is the current Head of the Division of Gastroenterology at Vancouver General Hospital.
He graduated from Leeds University in England, with subsequent training in internal medicine and gastroenterology in England as well as here in Vancouver. He has undertaken research in both countries including a translational science fellowship in a starfish laboratory, where he learnt about biochemical signal transduction cascades. He has applied this information to his areas of interest and research that includes inflammatory bowel disease and its complications such as cancer.
He is the Principal Investigator on numerous clinical trials at Vancouver General Hospital, exploring the use of novel therapeutic compounds/targets in patients affected by inflammatory bowel disease. He is fluent in English and Punjabi.